View in EDS

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Saved in:
Bibliographic Details
Title: Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.
Authors: Alduaij W; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Champagne JN; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Hematology and Medical Oncology, Hôpital du Sacre-Coeur de Montréal, Montreal, QC, Canada., Collinge B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Jiang A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Hilton LK; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Boyle M; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Meissner B; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Slack GW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Farinha P; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Craig JW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology, University of Virginia Health System, Charlottesville, VA., Savage KJ; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Villa D; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Freeman CL; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Blood and Marrow Transplant and Cellular Therapy, Moffitt Cancer Center, Tampa, FL., Mungall AJ; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Steidl C; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Source: Blood advances [Blood Adv] 2026 Jan 27; Vol. 10 (2), pp. 320-333.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41071951
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alduaij+W%22">Alduaij W</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Sehn+LH%22">Sehn LH</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Champagne+JN%22">Champagne JN</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Hematology and Medical Oncology, Hôpital du Sacre-Coeur de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Collinge+B%22">Collinge B</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ben-Neriah+S%22">Ben-Neriah S</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Jiang+A%22">Jiang A</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Hilton+LK%22">Hilton LK</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Boyle+M%22">Boyle M</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Meissner+B%22">Meissner B</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Slack+GW%22">Slack GW</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Farinha+P%22">Farinha P</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Craig+JW%22">Craig JW</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology, University of Virginia Health System, Charlottesville, VA.<br /><searchLink fieldCode="AU" term="%22Savage+KJ%22">Savage KJ</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Villa+D%22">Villa D</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Gerrie+AS%22">Gerrie AS</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Blood and Marrow Transplant and Cellular Therapy, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Mungall+AJ%22">Mungall AJ</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Steidl+C%22">Steidl C</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Scott+DW%22">Scott DW</searchLink>; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jan 27; Vol. 10 (2), pp. 320-333.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41071951
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025017282
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 320
    Titles:
      – TitleFull: Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alduaij W
      – PersonEntity:
          Name:
            NameFull: Sehn LH
      – PersonEntity:
          Name:
            NameFull: Champagne JN
      – PersonEntity:
          Name:
            NameFull: Collinge B
      – PersonEntity:
          Name:
            NameFull: Ben-Neriah S
      – PersonEntity:
          Name:
            NameFull: Jiang A
      – PersonEntity:
          Name:
            NameFull: Hilton LK
      – PersonEntity:
          Name:
            NameFull: Boyle M
      – PersonEntity:
          Name:
            NameFull: Meissner B
      – PersonEntity:
          Name:
            NameFull: Slack GW
      – PersonEntity:
          Name:
            NameFull: Farinha P
      – PersonEntity:
          Name:
            NameFull: Craig JW
      – PersonEntity:
          Name:
            NameFull: Savage KJ
      – PersonEntity:
          Name:
            NameFull: Villa D
      – PersonEntity:
          Name:
            NameFull: Gerrie AS
      – PersonEntity:
          Name:
            NameFull: Freeman CL
      – PersonEntity:
          Name:
            NameFull: Mungall AJ
      – PersonEntity:
          Name:
            NameFull: Steidl C
      – PersonEntity:
          Name:
            NameFull: Scott DW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 01
              Text: 2026 Jan 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1